Adherence to quality indicators of Barrett’s esophagus surveillance: where do we stand?

Endoscopy 2017; 49(11): 1113
DOI: 10.1055/s-0043-115005

Letter to the editor

Authors

Donevan Westerveld

¹Department of Medicine, University of Florida, Gainesville, Florida, United States
Dennis Yang

²Division of Gastroenterology and Hepatology, University of Florida, Gainesville, Florida, United States

References
1 El-Serag HB, Naik AD, Duan Z. et al. Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett’s oesophagus. Gut 2016; 65: 1252-1260
2 Sharma P, Dent J, Armstron D. et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
3 Abela J-E, Going J, Mackenzie J. et al. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 2008; 103: 850-855
4 Ooi J, Wilson P, Walker G. et al. Dedicated Barrett’s surveillance sessions managed by trained endoscopists improve dysplasia detection rate. Endoscopy 2017; 49: 524-528
5 Westerveld D, Khullar V, Mramba L. et al. Adherence to quality indicators for the diagnosis and management of Barrett’s esophagus: a single-center retrospective analysis. Gastroenterology 2017; 152: S448-S449